Claims data analysis on the dispensing of tricyclic antidepressants among patients with dementia in Germany

Show simple item record

dc.identifier.uri Hessmann, Philipp Zeidler, Jan Stahmeyer, Jona Eberhard, Sveja Vogelgsang, Jonathan Abdel-Hamid, Mona Wolff-Menzler, Claus Wiltfang, Jens Kis, Bernhard 2019-08-26T07:56:07Z 2019-08-26T07:56:07Z 2019
dc.identifier.citation Hessmann, P.; Zeidler, J.; Stahmeyer, J.; Eberhard, S.; Vogelgsang, J. et al.: Claims data analysis on the dispensing of tricyclic antidepressants among patients with dementia in Germany. In: Frontiers in Pharmacology 10 (2019), 841. DOI:
dc.description.abstract Objective: A restrictive use of tricyclic antidepressants (TCA) in patients with dementia (PwD) is recommended due to the hazard of anticholinergic side effects. We evaluated the frequency of TCA dispensing in PwD over a period of 1 year and the use of TCA before and after the incident diagnosis of dementia. Methods: This analysis was based on administrative data from a German statutory health insurance for a period of 2 years. Totally, 20,357 patients with an incident diagnosis of dementia in 2014 were included. We evaluated the dispensing of TCA in 2015. Subgroup analyses were conducted to evaluate associations between the incident diagnosis of dementia and modifications in TCA dispensing. Results: In 2015, 1,125 dementia patients (5.5%) were treated with TCA and 31% were medicated with TCA in all four quarters of 2015. Most dispensings were conducted by general practitioners (67.9%). On average, patients received 3.7 ± 2.6 dispensings per year. Amitriptyline (56.3%), doxepin (26.8%), and trimipramine (16.8%) were dispensed most often. Subgroup analyses revealed that the dispensing of TCA remained mainly unchanged following the incident diagnosis. Conclusion: A relevant number of PwD were treated with TCA. To maintain the patients' safety, an improved implementation of guidelines for the pharmaceutical treatment of PwD in healthcare institutions might be required. Since 68% of the patients suffered from depression, future studies should further evaluate the indications for TCA. Copyright © 2019 Hessmann, Zeidler, Stahmeyer, Eberhard, Vogelgsang, Abdel-Hamid, Wolff-Menzler, Wiltfang and Kis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. eng
dc.language.iso eng
dc.publisher Lausanne : Frontiers Media S.A.
dc.relation.ispartofseries Frontiers in Pharmacology 10 (2019)
dc.rights CC BY 4.0 Unported
dc.subject Antidepressants eng
dc.subject Claims data eng
dc.subject Dementia eng
dc.subject Pharmacotherapy eng
dc.subject Tricyclic eng
dc.subject.ddc 610 | Medizin, Gesundheit ger
dc.title Claims data analysis on the dispensing of tricyclic antidepressants among patients with dementia in Germany
dc.type Article
dc.type Text
dc.relation.issn 1663-9812
dc.bibliographicCitation.volume 10
dc.bibliographicCitation.firstPage 841
dc.description.version publishedVersion
tib.accessRights frei zug�nglich

Files in this item

This item appears in the following Collection(s):

Show simple item record


Search the repository


My Account

Usage Statistics